Earnings Call · Q3 FY2024·2024-11-07

Q3 24EPS +11.76%·Rev n/aQ2 24EPS +30.23%·Rev n/aQ1 24EPS +26.67%·Rev n/aQ4 23EPS +14.81%·Rev n/a⚠ consensus missing

CATALYST PHARMACEUTICALS, INC. CPRX

Michael Kalb — Chief Financial Officer

Richard Daly — President and Chief Executive Officer

Jeffrey Del Carmen — Chief Commercial Officer

+3.4%1d on move date+0.9% vs SPY3d+9.0%5d+4.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPRX calls or request research access.

More CPRX calls Browse calls Request research access